RU93004416A - PHARMACEUTICAL AGENT IN THE FORM OF MICROCAPSULES AND METHOD FOR THEIR RECEPTION - Google Patents

PHARMACEUTICAL AGENT IN THE FORM OF MICROCAPSULES AND METHOD FOR THEIR RECEPTION

Info

Publication number
RU93004416A
RU93004416A RU93004416/14A RU93004416A RU93004416A RU 93004416 A RU93004416 A RU 93004416A RU 93004416/14 A RU93004416/14 A RU 93004416/14A RU 93004416 A RU93004416 A RU 93004416A RU 93004416 A RU93004416 A RU 93004416A
Authority
RU
Russia
Prior art keywords
pharmaceutical agent
microcapsules
reception
shell
substance
Prior art date
Application number
RU93004416/14A
Other languages
Russian (ru)
Other versions
RU2110255C1 (en
Inventor
Пеллингер Норберт
Михаэлис Йоганнес
Бенке Клаус
Рупп Роланд
Бюхелер Манфред
Original Assignee
Байер Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4200821A external-priority patent/DE4200821A1/en
Application filed by Байер Аг filed Critical Байер Аг
Publication of RU93004416A publication Critical patent/RU93004416A/en
Application granted granted Critical
Publication of RU2110255C1 publication Critical patent/RU2110255C1/en

Links

Claims (1)

Фармацевтическое средство в виде микрокапсул, содержащее активное вещество с крайне неприятными органолептическими свойствами, заключенное в оболочку, отличительная особенность которого заключается в том, что вещество представляет собой ангидрит своей основной формы, а оболочка содержит лак из водонерастворимых нейтральных сложных метиловых и/или этиловых эфиров полиметакриловой кислоты и/или четвертичных аммониевых соединений полиметакриловой кислоты и/или этилцеллюлозы, может содержать также дополнительные водорастворимые полимеры, пластификаторы, смачиватели и другие обычные вспомогательные вещества. Другим объектом изобретения является способ фармацевтического препарата.Pharmaceutical agent in the form of microcapsules containing the active substance with extremely unpleasant organoleptic properties, enclosed in a shell, a distinctive feature of which is that the substance is an anhydrite of its basic form, and the shell contains a varnish from water-insoluble neutral polymethacrylate acids and / or quaternary ammonium compounds of polymethacrylic acid and / or ethylcellulose, may also contain additional water-soluble fields imers, plasticizers, wetting agents and other common excipients. Another object of the invention is a pharmaceutical preparation method.
RU93004416/14A 1992-01-15 1993-01-15 Pharmaceutical agent as microcapsule and a method of its preparing RU2110255C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4200821A DE4200821A1 (en) 1992-01-15 1992-01-15 TASTE-MASKED PHARMACEUTICAL AGENTS
DEP4200821.2 1992-01-15

Publications (2)

Publication Number Publication Date
RU93004416A true RU93004416A (en) 1995-03-10
RU2110255C1 RU2110255C1 (en) 1998-05-10

Family

ID=6449525

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93004416/14A RU2110255C1 (en) 1992-01-15 1993-01-15 Pharmaceutical agent as microcapsule and a method of its preparing

Country Status (24)

Country Link
US (2) US5695784A (en)
EP (1) EP0551820B1 (en)
JP (1) JP3734279B2 (en)
KR (1) KR100288523B1 (en)
CN (1) CN1052399C (en)
AT (1) ATE186212T1 (en)
AU (1) AU670763B2 (en)
CA (1) CA2087146C (en)
CZ (1) CZ283787B6 (en)
DE (2) DE4200821A1 (en)
DK (1) DK0551820T3 (en)
ES (1) ES2141117T3 (en)
GR (1) GR3032382T3 (en)
HK (1) HK1005987A1 (en)
HU (2) HU219592B (en)
IL (1) IL104362A (en)
MX (1) MX9207630A (en)
MY (1) MY111177A (en)
NZ (1) NZ245658A (en)
PL (1) PL175569B1 (en)
RU (1) RU2110255C1 (en)
SK (1) SK280999B6 (en)
TW (1) TW366286B (en)
ZA (1) ZA93234B (en)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200821A1 (en) * 1992-01-15 1993-07-22 Bayer Ag TASTE-MASKED PHARMACEUTICAL AGENTS
DE29502547U1 (en) * 1995-02-16 1995-03-30 Roehm Gmbh Thermoplastic coating and binding agent for pharmaceutical forms
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
US5766622A (en) * 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
DE19706978A1 (en) * 1997-02-21 1998-08-27 Ulrich Dr Posanski Combination preparation for oral antibiotics
FI111796B (en) * 1997-05-28 2003-09-30 Finnfeeds Finland Oy Solid betaine product, process for its preparation and its use
DE19809719A1 (en) * 1998-03-06 1999-09-09 Roehm Gmbh Aqueous dispersion for binder and coating for medicine
US5976507A (en) * 1998-06-04 1999-11-02 Colgate Palmolive Company Dentrifice composition containing encapsulated reactive ingredients
US6727283B2 (en) * 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6270807B1 (en) * 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
DE19913692A1 (en) * 1999-03-25 2000-09-28 Basf Ag Mechanically stable pharmaceutical dosage forms containing liquid or semi-solid surface-active substances
GB9911546D0 (en) * 1999-05-19 1999-07-21 Core Technologies Limited Release of poorly soluble agents
DE19930557B4 (en) * 1999-07-02 2005-12-08 Bayer Healthcare Ag Process for the preparation of hydrates of ciprofloxacin and of ciprofloxacin anhydrate containing pharmaceutical compositions
AU773555B2 (en) 1999-07-09 2004-05-27 Ortho-Mcneil Pharmaceutical, Inc. Taste masked pharmaceutical liquid formulations
FR2798289B1 (en) * 1999-09-15 2004-12-31 Cll Pharma QUICKLY DELITING MOUTH GALENIC FORMS AND THEIR PREPARATION METHOD
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
DE60005469T3 (en) * 1999-12-22 2007-08-09 Dsm Ip Assets B.V. Pharmaceutical composition containing ascorbic acid and pectin
DE10026698A1 (en) 2000-05-30 2001-12-06 Basf Ag Self-emulsifying active ingredient formulation and use of this formulation
WO2001091730A1 (en) 2000-05-31 2001-12-06 Drugtech Corporation Mineral supplement
DE10031043A1 (en) 2000-06-26 2002-02-14 Bayer Ag Retarded preparations of quinolone antibiotics and process for their preparation
TR200300731T2 (en) 2000-11-28 2004-08-23 Fmc Corporation Composition of edible PGA coating
US20020122824A1 (en) * 2001-01-24 2002-09-05 Francisco Cabrera Solid phase dispersion of quinolone-or naphthyridonecarboxylic acids
CA2440069A1 (en) 2001-03-05 2002-09-12 Ortho-Mcneil Pharmaceutical, Inc. Taste masked pharmaceutical compositions
JP4705747B2 (en) * 2001-05-30 2011-06-22 ユーロセルティック ソシエテ アノニム Pharmaceutical composition
CA2458209C (en) * 2001-09-03 2010-11-09 Dsm Ip Assets B.V. Compositions comprising pectin and ascorbic acid
JP4619658B2 (en) * 2002-03-12 2011-01-26 富山化学工業株式会社 Pleasant taste oral suspension and method
US7790215B2 (en) * 2002-03-26 2010-09-07 Purdue Pharma Lp Sustained-release gel coated compositions
PT1492511E (en) 2002-04-09 2009-04-09 Flamel Tech Sa Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
US20030198892A1 (en) * 2002-04-22 2003-10-23 General Electric Company Limited play data storage media and method for limiting access to data thereon
US20030205323A1 (en) * 2002-04-22 2003-11-06 General Electric Company Method for making limited play data storage media
WO2004004682A2 (en) * 2002-07-02 2004-01-15 Laboratorios S.A.L.V.A.T., S.A. Stable oily suspension of microgranules
US20050269722A1 (en) * 2002-07-17 2005-12-08 Stefano De Luigi Brushci Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate
US20040208936A1 (en) * 2002-07-22 2004-10-21 Roland Chorin Novel compositions
KR20040011087A (en) * 2002-07-27 2004-02-05 주식회사 씨티씨바이오 A process for preparing roxythromycin granules having masked taste and smell
US20040087692A1 (en) * 2002-10-30 2004-05-06 Dixit Arun Nandkishor Method for preparation of an anthraquinone colorant composition
EP1581197A1 (en) * 2002-12-11 2005-10-05 Ranbaxy Laboratories, Limited Coating composition for taste masking coating and methods for their application and use
US20040146553A1 (en) * 2002-12-23 2004-07-29 Aventis Pharma S.A. Compositions for oral administration of active principles requiring masking of taste
US20040170686A1 (en) * 2003-01-31 2004-09-02 Fredrickson Jennifer K. Suspension vehicle for coated drug particles
DK1594500T3 (en) * 2003-02-10 2011-01-24 Bayer Schering Pharma Ag Treatment of bacterial diseases of the respiratory organs by local application of fluoroquinolones
US20040192781A1 (en) * 2003-03-31 2004-09-30 Haley Eugene T. Method of administration for metoclopramide and pharmaceutical formulation therefor
US20050137265A1 (en) * 2003-03-31 2005-06-23 Haley Eugene T. Rapidly dissolving metoclopramide solid oral dosage and method thereof
US7202292B2 (en) * 2003-07-15 2007-04-10 General Electric Company Colored polymeric resin composition with 1,8-diaminoanthraquinone derivative, article made therefrom, and method for making the same
US7087282B2 (en) * 2003-07-15 2006-08-08 General Electric Company Limited play optical storage medium, method for making the same
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
JP2005343800A (en) * 2004-05-31 2005-12-15 Lion Corp Coated caffeine particle, solid preparation and sleepiness-preventing medicine
US7854943B2 (en) * 2004-06-24 2010-12-21 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
BRPI0612752B8 (en) * 2005-06-21 2021-05-25 Merck Patent Gmbh solid pharmaceutical composition comprising (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chroman
US20080213441A1 (en) * 2006-12-27 2008-09-04 Cathy Jean Ludwig Reduction of Astringency in Polyphenol Compositions
BRPI0701693A2 (en) * 2007-05-10 2008-12-23 Inst Pesquisas Sao Paulo encapsulation process of chemically active substances and resulting encapsulated product
KR100867639B1 (en) 2007-06-08 2008-11-10 (주)다산메디켐 Bitterness-masked donepezil hydrochloride-containing particles, pharmaceutical composition comprising the same, and process for the preparation thereof
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
DE102008035542A1 (en) 2008-07-30 2010-02-04 Siemens Aktiengesellschaft Method for determining measurement data from the stomach of a patient
CA2748034A1 (en) * 2008-12-23 2010-07-01 Pharmasset, Inc. Purified 2'-deoxy'2'-fluoro-2'-c-methyl-nucleoside-phosphoramidate prodrugs for the treatment of viral infections
PA8855601A1 (en) 2008-12-23 2010-07-27 NUCLEOSID FORFORMIDATES
CN102325783A (en) 2008-12-23 2012-01-18 法莫赛特股份有限公司 Synthesis of purine nucleosides
TWI576352B (en) 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 Nucleoside phosphoramidates
BRPI0925100A2 (en) 2009-06-02 2016-07-19 Dow Global Technologies Llc osmotic dosage form and process for preparing an osmotic dosage form
CA2782285A1 (en) * 2009-12-02 2011-06-09 Luigi Mapelli Fexofenadine microcapsules and compositions containing them
US20110236494A1 (en) * 2010-03-04 2011-09-29 Ranbaxy Laboratories Limited Ciprofloxacin oral suspension
US8563530B2 (en) 2010-03-31 2013-10-22 Gilead Pharmassel LLC Purine nucleoside phosphoramidate
SG184323A1 (en) 2010-03-31 2012-11-29 Gilead Pharmasett Llc Stereoselective synthesis of phosphorus containing actives
TW201136945A (en) 2010-03-31 2011-11-01 Pharmasset Inc Purine nucleoside phosphoramidate
NZ603545A (en) 2010-04-12 2013-10-25 Zhaveri Pharmakem Pvt Ltd S Ciprofloxacin dry syrup composition
CN101985044B (en) * 2010-07-16 2013-10-23 钟术光 Taste-masking medicinal coating composition
CA2818853A1 (en) 2010-11-30 2012-06-07 Gilead Pharmasset Llc 2'-spirocyclo-nucleosides for use in therapy of hcv or dengue virus
CN102526124B (en) * 2011-01-31 2013-11-20 成都科尔医药技术有限公司 Traditional Chinese medicinal powder and preparation method thereof
BR112014003061A2 (en) 2011-08-12 2017-02-21 Boehringer Ingelheim Vetmedica Gmbh masked flavor pharmaceutical composition
ES2761265T3 (en) 2013-03-15 2020-05-19 Aprecia Pharmaceuticals LLC Rapidly dispersible oxcarbazepine dosage form
CA2906172C (en) 2013-03-15 2021-12-21 Aprecia Pharmaceuticals Company Rapidly dispersible dosage form of topiramate
RU2599007C1 (en) * 2015-08-24 2016-10-10 Александр Александрович Кролевец Method of producing nanocapsules of ciprofloxacin hydrochloride in sodium alginate
ITUB20155193A1 (en) * 2015-11-03 2017-05-03 Italfarmaco Spa Physically and chemically stable oral Givinostat suspensions
CN105343028B (en) * 2015-11-25 2018-08-21 万邦德制药集团股份有限公司 A kind of pharmaceutical composition of Norfloxacin and preparation method thereof
EP3883546A1 (en) 2018-11-21 2021-09-29 Rosemont Pharmaceuticals Ltd Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
CN116459222A (en) * 2023-04-20 2023-07-21 山东中医药大学附属医院 Pivelum bromide composition, preparation and application thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8203953D0 (en) * 1982-06-24 1982-06-24 Astra Laekemedel Ab PHARMACEUTICAL MIXTURE
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
DE3808277A1 (en) * 1988-03-12 1989-09-21 Bayer Ag METHOD AND DEVICE FOR SPIRAL LAYER SPRAY GRANULATION
EP0163836B1 (en) * 1984-04-07 1988-10-12 Bayer Ag Process and apparatus for the production of granules
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
US4971791A (en) * 1985-08-26 1990-11-20 The Procter & Gamble Company Taste masking compositions
US4764375A (en) * 1985-09-11 1988-08-16 Kv Pharmaceutical Company Sachet drug delivery system
EP0230811B1 (en) * 1986-01-24 1992-06-03 Valeo Electronique Ignition coil with a closed magnetic circuit
SE8605515D0 (en) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A LIQUID DOSAGE FORM FOR ORAL ADMINISTRATION OF A PHARMACEUTICALLY ACTIVE SUBSTANCE
FI77573C (en) * 1987-05-08 1989-04-10 Orion Yhtymae Oy New texture.
NL193682C (en) * 1987-05-14 2000-07-04 Glaxo Group Ltd Coated Cefuroxime Maxetil Composition.
IE59934B1 (en) * 1987-06-19 1994-05-04 Elan Corp Plc Liquid suspension for oral administration
GB8723896D0 (en) * 1987-10-12 1987-11-18 Aps Research Ltd Controlled-release formulation
DE3808116A1 (en) * 1988-03-11 1989-09-21 Bayer Ag ZIGZAG SIFTER
DE3900811A1 (en) * 1989-01-13 1990-07-19 Kali Chemie Pharma Gmbh NEW MEDICINE
DE3920082A1 (en) * 1989-06-20 1991-03-07 Roehm Gmbh FILM-FORMING AQUEOUS COATING AGENT FOR SOLID MEDICINAL PRODUCTS, METHOD FOR THE PRODUCTION AND USE THEREOF
US5082669A (en) * 1989-07-20 1992-01-21 Dainippon Pharmaceutical Co., Ltd. Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked
ZA923474B (en) * 1991-05-20 1993-01-27 Marion Merrell Dow Inc Diltiazem formulation
DE4200821A1 (en) * 1992-01-15 1993-07-22 Bayer Ag TASTE-MASKED PHARMACEUTICAL AGENTS

Similar Documents

Publication Publication Date Title
RU93004416A (en) PHARMACEUTICAL AGENT IN THE FORM OF MICROCAPSULES AND METHOD FOR THEIR RECEPTION
IL104362A (en) Pharmaceutical compositions containing active ingredients which are flavour-masked by microencapsulation
KR890009418A (en) Concentrated stabilized microbubble ultrasound imaging agent
DK0431877T3 (en) Cimetidine-containing pharmaceuticals
WO1994005253A3 (en) Deodorizing cosmetics containing fatty acids
HUT67634A (en) Herbicides containing sulfonamides as actives ingredient and process for preparation of the active ingredients
IE940583L (en) Topical antimicrobial pharmaceutical compositions
ITPD910102A0 (en) PROCESS FOR THE PREPARATION OF MICROSPHERES CONTAINING BIOLOGICALLY ACTIVE COMPONENTS
BR9006934A (en) STABILIZED AQUEOUS FORMULATIONS OF SMALL PEPTIDES
HU906212D0 (en) Herbicide preparations containing oxazole- and tiazole-carbonic acid -amides and process for the preparation of the active agents
KR920701213A (en) Methylenediphosphonic acid compound and anti-inflammatory agent using it as an active ingredient
DE3881907D1 (en) PHENOXYCARBONIC ACID COMPOUNDS AND THESE WEED KILLING AGENT CONTAINING IT AS ACTIVE SUBSTANCE.
DE59307983D1 (en) Concentrated, aqueous liquid formulations of color formers
NO910874L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PIPERIDE INGREDIENTS.
FR2764508B1 (en) NOVEL LIPOSOMAL VECTORS OF ACTIVE INGREDIENTS
DE68920896T2 (en) N2- (1-carboxy-3-phenylpropyl) -L-lysine derivatives and process for the preparation of lysinopril using this compound.
NO172495C (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE, NON-Saturated AMINO ACID COMPOUNDS
MA25414A1 (en) CARBOXYLIC ACID AMIDES OF PHENYLCYCLOHEXANE WHICH HAVE AN INHIBITORING EFFECT OF ADENOSINE BINDING.
HU908294D0 (en) Fungicide preparations containing pyridyl-cyclopropane as active agent and process for the preparation of the active agents
FR2593703B1 (en) APPLICATION OF BUTYL-4-DIPHENYL-1,2-PYRAZOLIDINE-DIONE-3,5 AS ANTIVIRAL AGENT IN HUMANS OR ANIMALS
AR243862A1 (en) Derivatives of phenoxy-alkane-carboxylic acids that are active as herbicides.
IT1228376B (en) SPHERICAL KNOT PERFECTED FOR SPATIAL RETICULAR STRUCTURES.
RU93056252A (en) PREPARATION FOR MASSAGE "MALAVIT"
TH16602A (en) Mixture of concentrated biodegradable quaternary ammonium fabric softener and intermediate iodine-value polyunsaturated fatty acid chain compounds.
FR2594694B3 (en) COMBINATION CONTAINING, AS ACTIVE INGREDIENTS, A MUCOLYTIC AGENT AND ADENOSINE TRIPHOSPHORIC ACID OR A SALT THEREOF